Recombinant Human VEGF165|重組人血管內(nèi)皮生長(zhǎng)因子
產(chǎn)品名稱: Recombinant Human VEGF165|重組人血管內(nèi)皮生長(zhǎng)因子
產(chǎn)品型號(hào): C22-105-05
產(chǎn)品展商: PERFEMIKER
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Recombinant Human VEGF165|重組人血管內(nèi)皮生長(zhǎng)因子 現(xiàn)貨促銷，
>95% by SDS-PAGE and HPLC analyses.
Recombinant Human VEGF165|重組人血管內(nèi)皮生長(zhǎng)因子
的詳細(xì)介紹
產(chǎn)品名稱：Recombinant Human VEGF165|重組人血管內(nèi)皮生長(zhǎng)因子
單 位：支
Recombinant Human VEGF165|重組人血管內(nèi)皮生長(zhǎng)因子，國(guó)產(chǎn)細(xì)胞因子，cytokine
產(chǎn)品詳細(xì)介紹：
C22-105-05 2μg/￥500 10μg/￥1000 1mg/詢價(jià)
Purity:
>95% by SDS-PAGE and HPLC analyses.
Biological Activity:
Fully biologically active when compared to standard. Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-8.0 ng/ml.
Storage:
This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
